Source: International Congress 2015 – Thoracic oncology: from fusion genes to treatment



Rating:

Share or cite this content

Citations should be made in the following way:
Thierry Berghmans (Brussels, Belgium). Management of patients with a tumoural fusion gene. International Congress 2015 – Thoracic oncology: from fusion genes to treatment

Member's Comments

No comment yet.

Related content which might interest you: Survival outcomes of patients diagnosed with lung adenocarcinoma with ALK gene rearrangement Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient Source: ERJ Open Res, 7 (1) 00582-2020; 10.1183/23120541.00582-2020 Year: 2021 The art of detecting EML4-ALK gene rearrangements in NSCLC patients – Immediate implications for patient care Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Chronic lung disease in two patients with new integrin alfa3 gene mutations Source: International Congress 2016 – Orphan diseases II Year: 2016 Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Microarray gene expression profiles in lung tissue of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007 Expression of apoptosis gene related protein in thymoma and invasive thymoma Source: Eur Respir J 2005; 26: Suppl. 49, 330s Year: 2005 Results of surgical treatment of patients with inflammatory pseudotumors of thoracic localization Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020 Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies Year: 2003 Interstitial lung disease caused by filamin A gene mutations: Clinical course of three paediatric cases Source: International Congress 2016 – Orphan diseases II Year: 2016 Proteomic based identification of specific proteins correlated with prognosis of patients with surgically resected stage I lung adenocarcinoma Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Drugs that target fusion genes Source: International Congress 2015 – Thoracic oncology: from fusion genes to treatment Year: 2015 Prognostic value of promoter hypermethylation of tumor suppressor genes in malignant pleural fluid Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Surgical treatment of patients with multiple primary and metastatic neoplasms of lung and other organs Source: Eur Respir J 2004; 24: Suppl. 48, 530s Year: 2004 Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth in vivo by retrovirus-mediated gene transfer Source: Annual Congress 2002 - Thoracic oncology: biology Year: 2002 Proinflammatory cytokine gene polymorphisms in the prediction of clinical course in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient Source: Eur Respir J , 49 (4)  1602149; DOI: 10.1183/13993003.02149-2016 Year: 2017